The medication, called Rekovelle, was launched last year by Ferring, a privately held Swiss multinational pharmaceutical company, which in 2005 acquired Bio-Technology General (Israel) Ltd. (BTG).

English: Ferring Pharmaceuticals’ global headquarters in St-Prex, Switzerland (photo credit: Wikimedia Commons) Biotechnology General (BTG), an Israeli-based company, launched a production line ...

Graff first joined Ferring in 2002 as VP of global marketing, business development and medical affairs, based in Copenhagen. After leading the acquisition and integration of Israeli biopharmaceutical ...